Zim Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 27 June 2024.Powered by Capital Market - Live News

Net profit of Zim Laboratories rose 11.74% to Rs 8.09 crore in the quarter ended March 2024 as against Rs 7.24 crore during the previous quarter ended March 2023. Sales rose 11.81% to Rs 117.86 crore in the quarter ended March 2024 as against Rs 105.41 crore during the previous quarter ended March 2023.For the full year,net profit declined 29.39% to Rs 17.25 crore in the year ended March 2024 as against Rs 24.43 crore during the previous year ended March 2023. Sales declined 7.81% to Rs 367.42 crore in the year ended March 2024 as against Rs 398.53 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales117.86105.41 12 367.42398.53 -8 OPM %13.2814.66 -11.2513.05 - PBDT14.9014.87 0 39.5952.82 -25 PBT11.009.94 11 23.6435.36 -33 NP8.097.24 12 17.2524.43 -29 Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 13 May 2024Powered by Capital Market - Live News

Net profit of Zim Laboratories declined 27.58% to Rs 4.78 crore in the quarter ended December 2023 as against Rs 6.60 crore during the previous quarter ended December 2022. Sales declined 4.64% to Rs 96.29 crore in the quarter ended December 2023 as against Rs 100.97 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales96.29100.97 -5 OPM %11.9812.97 - PBDT10.9513.88 -21 PBT7.019.98 -30 NP4.786.60 -28 Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 23 December 2023.Powered by Capital Market - Live News